BALTIMORE, Dec. 8, 2021 /PRNewswire/ -- Medifast, Inc.
(NYSE: MED), the global company behind one of the fastest-growing
health and wellness communities, OPTAVIA®,
announced today that its Board of Directors has declared a
$1.42 quarterly cash dividend to its
stockholders. The quarterly cash dividend of $1.42 per share is payable on February 8, 2022 to stockholders of record as of
the close of business on December 21,
2021.
Medifast expects to maintain a program of paying dividends on a
quarterly basis. However, the declaration of dividends in the
future is subject to the discretion of the company's Board of
Directors, who will evaluate the company's dividend program from
time to time based on factors that it deems relevant.
About Medifast®:
Medifast (NYSE: MED) is the global company behind one of the
fastest-growing health and wellness
communities, OPTAVIA®, which offers
scientifically developed products, clinically proven plans and the
support of Coaches and a Community to help Clients
achieve Lifelong Transformation, One Healthy Habit at a
Time®. Based on more than 40 years of experience,
Medifast has redefined direct selling by combining the best aspects
of the model. Its community of independent OPTAVIA
Coaches has impacted 2 million lives and teaches Clients how to
develop holistic healthy habits through the proprietary Habits of
Health® Transformational System. Medifast is traded
on the New York Stock Exchange and ranked second
on FORTUNE's 100 Fastest-Growing Companies list in 2020.
The company was also named to Forbes' 100 Most Trustworthy
Companies in America list in 2017. For more information,
visit MedifastInc.com or OPTAVIA.com and
follow @Medifast on Twitter.
Forward Looking Statements
Please Note: This release contains "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as
amended, and the Private Securities Litigation Reform Act of 1995.
These forward-looking statements relate to future dividends.
Similarly, descriptions of Medifast's objectives, strategies,
plans, goals or targets contained herein are also considered
forward-looking statements. These statements are based on the
current expectations of the management of Medifast and are subject
to certain events, risks, uncertainties, and other factors. Some of
these factors include, among others, risks associated with
Medifast's direct-to-consumer business model, the impact of rapid
growth on Medifast's systems, disruptions in Medifast's supply
chain, Medifast's inability to continue to develop new services and
products, effectiveness of Medifast's advertising and marketing
programs, including use of social media by independent
OPTAVIA Coaches, Medifast's inability to maintain and grow
the network of independent OPTAVIA Coaches, the departure of
one or more key personnel, Medifast's inability to protect against
online security risks, to protect its brand, to protect against
product liability claims, Medifast's planned growth into domestic
and international markets, adverse publicity associated with
Medifast's products, Medifast's inability to continue declaring
dividends, fluctuations of Medifast's common stock market
price, the impact of the COVID-19 pandemic on Medifast's
results, the severity, length and ultimate impact of COVID-19 on
people and economies, increases in competition, litigation,
consequences of other geopolitical events, natural disasters, acts
of war, or climate change, activist investors, regulatory changes,
market conditions and resulting impact on consumer spending, a
failure of internal control over financial reporting and any
limitations imposed by Medifast's debt agreements. Although
Medifast believes that the expectations, statements, and
assumptions reflected in these forward-looking statements are
reasonable, it cautions readers to always consider all of the risk
factors and any other cautionary statements carefully in evaluating
each forward-looking statement in this release, as well as those
set forth in its Annual Report on Form 10-K for the fiscal year
ended December 31, 2020, its
Quarterly Reports on Form 10-Q for the quarters ended March 31, 2021, June 30,
2021, September 30, 2021, and
other filings filed with the United States Securities and Exchange
Commission, including its current reports on Form 8-K. All of the
forward-looking statements contained herein speak only as of the
date of this release.
MED-F
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medifast-inc-announces-quarterly-dividend-301440616.html
SOURCE Medifast, Inc.